コンテンツへスキップ
Merck

P-073

Supelco

Pentazocine solution

1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

ログイン組織・契約価格を表示する


About This Item

実験式(ヒル表記法):
C19H27NO
CAS番号:
分子量:
285.42
EC Number:
UNSPSCコード:
41116107
NACRES:
NA.24

グレード

certified reference material

形状

liquid

特徴

Snap-N-Spike®/Snap-N-Shoot®

包装

ampule of 1 mL

メーカー/製品名

Cerilliant®

drug control

Narcotic Licence Schedule A (Switzerland); psicótropo (Spain); Decreto Lei 15/93: Tabela IIC (Portugal)

濃度

1.0 mg/mL in methanol

テクニック

gas chromatography (GC): suitable
liquid chromatography (LC): suitable

アプリケーション

forensics and toxicology

フォーマット

single component solution

保管温度

2-8°C

SMILES記法

O=C(C1=C2C(NC(CCOCCC(O)=O)=O)=CC=C1)N([C@H]3CCC(NC3=O)=O)C2=O.O=C(C4=C5C(NC(CCOCCC(O)=O)=O)=CC=C4)N([C@H]6CCC(NC6=O)=O)C5=O

InChI

1S/C19H27NO/c1-13(2)7-9-20-10-8-19(4)14(3)18(20)11-15-5-6-16(21)12-17(15)19/h5-7,12,14,18,21H,8-11H2,1-4H3

InChI Key

VOKSWYLNZZRQPF-UHFFFAOYSA-N

遺伝子情報

human ... SIGMAR1(10280)

詳細

A Certified Spiking Solution® applicable for use as starting material in calibrators or controls for a variety of LC/MS or GC/MS applications such as pain prescription monitoring, urine drug testing, forensic analysis, clinical toxicology, or pharmaceutical research. Pentazocine is a synthetic opioid analgesic used for treatment of moderate to severe pain. This painkiller is formulated in combination with naloxone or as a single agent under the trade names Talwin® and Talwin® NX, respectively.

法的情報

CERILLIANT is a registered trademark of Merck KGaA, Darmstadt, Germany
CERTIFIED SPIKING SOLUTION is a registered trademark of Cerilliant Corporation
Snap-N-Shoot is a registered trademark of Cerilliant Corporation
Snap-N-Spike is a registered trademark of Merck KGaA, Darmstadt, Germany
Talwin is a registered trademark of Hospira, Inc.

ピクトグラム

FlameSkull and crossbonesHealth hazard

シグナルワード

Danger

危険有害性情報

危険有害性の分類

Acute Tox. 3 Dermal - Acute Tox. 3 Inhalation - Acute Tox. 3 Oral - Flam. Liq. 2 - STOT SE 1

ターゲットの組織

Eyes

保管分類コード

3 - Flammable liquids

WGK

WGK 1

引火点(°F)

49.5 °F - closed cup

引火点(℃)

9.7 °C - closed cup


適用法令

試験研究用途を考慮した関連法令を主に挙げております。化学物質以外については、一部の情報のみ提供しています。 製品を安全かつ合法的に使用することは、使用者の義務です。最新情報により修正される場合があります。WEBの反映には時間を要することがあるため、適宜SDSをご参照ください。

消防法

第4類:引火性液体
アルコール類
危険等級II

Jan Code

P-073-CC:
P-073-1ML:4548173317793


試験成績書(COA)

製品のロット番号・バッチ番号を入力して、試験成績書(COA) を検索できます。ロット番号・バッチ番号は、製品ラベルに「Lot」または「Batch」に続いて記載されています。

以前この製品を購入いただいたことがある場合

文書ライブラリで、最近購入した製品の文書を検索できます。

文書ライブラリにアクセスする

Robert R Luedtke et al.
Brain research, 1441, 17-26 (2012-01-31)
We previously reported that the antipsychotic drug haloperidol, a multifunctional D2-like dopamine and sigma receptor subtype antagonist, has neuroprotective properties. In this study we further examined the association between neuroprotection and receptor antagonism by evaluating a panel of novel compounds
Christopher D King et al.
Pain, 154(3), 476-483 (2013-02-27)
A number of laboratory studies have confirmed the efficacy of opioid medication in reducing pain generated by a number of psychophysical modalities. However, one implicit assumption of clinical and experimental pain testing of analgesics is that the analgesic response is
Hideharu Hagiya et al.
Internal medicine (Tokyo, Japan), 52(3), 397-402 (2013-02-02)
An 88-year-old man died of streptococcal toxic shock syndrome due to a group G streptococcus infection that was possibly caused by an intramuscular injection given 30 hours earlier in his right deltoid muscle. The causative pathogen was later identified to
Hiroshi Oyake et al.
Masui. The Japanese journal of anesthesiology, 60(10), 1128-1134 (2011-11-25)
The effect of pentazocine on the bispectral index (BIS) has not been reported. In this study, we have examined whether pentazocine alters the bispectral index during nitrous oxide-sevoflurane anesthesia. Thirty surgical patients were enrolled in this double-blind, randomized study. Anesthesia
Leon F Tseng et al.
Life sciences, 89(23-24), 875-877 (2011-10-13)
We have previously demonstrated that pretreatment with (+)-morphine given intrathecally attenuates the intrathecal (-)-morphine-produced tail-flick inhibition. The phenomenon has been defined as antianalgesia against (-)-morphine-produced analgesia. Present experiments were then undertaken to determine if the antianalgesic effect induced by (+)-morphine

ライフサイエンス、有機合成、材料科学、クロマトグラフィー、分析など、あらゆる分野の研究に経験のあるメンバーがおります。.

製品に関するお問い合わせはこちら(テクニカルサービス)